HomeDRUG • NASDAQ
add
Bright Minds Biosciences Inc
Previous close
$27.81
Day range
$27.50 - $29.00
Year range
$0.93 - $79.02
Market cap
269.57M CAD
Avg Volume
29.04K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.24M | 591.00% |
Net income | -2.95M | -413.88% |
Net profit margin | — | — |
Earnings per share | -0.42 | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 55.68M | 838.57% |
Total assets | 56.47M | 764.61% |
Total liabilities | 726.81K | -14.07% |
Total equity | 55.74M | — |
Shares outstanding | 7.08M | — |
Price to book | 3.53 | — |
Return on assets | -14.10% | — |
Return on capital | -14.22% | — |
Cash Flow
Net change in cash
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -2.95M | -413.88% |
Cash from operations | -2.43M | -201.24% |
Cash from investing | — | — |
Cash from financing | 225.38K | 1,126.47% |
Net change in cash | -2.22M | -167.33% |
Free cash flow | -2.14M | -183.58% |
About
Founded
2017
Website
